Gastric Adenocarcinoma: Alan's Patient Story

Patient Info: Alan Gorman, 50s

Alan was receiving further chemotherapy after surgery because lymph nodes were involved.

Mr. Knight

Patient Info: Mr. Knight, Male, 60s

About a month after completing 5 weeks of chemotherapy and radiation, he was beginning to improve but still faced a long recovery.

Stage IV Lung Cancer: Anne's Patient Story

Patient Info: Anne LaPorte, Female | Stage IV

Biomarkers: Mutation identified by next-generation sequencing; specific mutation not reported

Metastatic Site: Spine; hips; lymph nodes; liver

As of November 2021, Anne was living with Stage IV lung cancer after oral treatment guided by tumor testing and later radiation, reporting a meaningful quality of life while advocating for self-advocacy and research.

The Patient StoryRead more →

Triple-Negative Breast Cancer: Sandra's Survivor Story

Patient Info: Sandra Monsonís, Female, 40s

Biomarkers: Triple-negative breast cancer; BRCA-positive

As of November 2021, Sandra felt healthy and happy after treatment for triple-negative breast cancer, BRCA-positive testing, double mastectomy, implant complication care, external prosthesis, and ovary removal to reduce future cancer risk.

Stage III Invasive Lobular Carcinoma: Martha's Survivor Story

Patient Info: Martha, Female, 40s | Stage III

Martha completed chemotherapy, bilateral mastectomies and 30 radiation treatments and remained on Tamoxifen as part of a planned 10-year course.

Lobular Breast Cancer AllianceRead more →

Breast Cancer: Kathleen's Survivor Story

Patient Info: Kathleen Shaffer, Female

As of November 2021, Kathleen was 10 months after lymph vessel transfer surgery and free of lymphedema symptoms after earlier breast cancer treatment; the story does not report formal cancer stage or recurrence status.

Cleveland ClinicRead more →

Breast Cancer: Theresa's Patient Story

Patient Info: Theresa Reynolds, Female, 70+

As of October 2021, Theresa had gone through mastectomy and radiation for breast cancer with coordinated support from her care team; stage, subtype and recurrence status were not reported.

Cleveland ClinicRead more →

BRCA1 Breast Cancer: Muriel's Survivor Story

Patient Info: Muriel Verger, Female, Under 40

Biomarkers: BRCA1 mutation

As of October 2021, Muriel described having completed about 9 months of treatment for triple-negative breast cancer diagnosed in 2015 and focused her message on survivorship, body image, and early detection.

YouTube (FR search)Read more →

Stage IV BRCA2 Invasive Lobular Carcinoma: Julie's Patient Story

Patient Info: Julie, Female, Under 40 | Stage IV

Biomarkers: BRCA2 mutation

Metastatic Site: Bone

Julie was first staged IIA with lobular breast cancer in 2019, then learned after chemotherapy, surgery, and radiation that the cancer had spread to her bones, making it Stage IV metastatic disease.

Lobular Breast Cancer AllianceRead more →

Stage IV Breast Cancer: Màrius's Patient Story

Patient Info: Màrius, Male | Stage IV

Metastatic Site: Bone: vertebra/cervical spine and ribs

As of October 2021, Màrius was living with metastatic male breast cancer described as dormant on lifelong medication after chemotherapy, radiation, 3 operations, and cyclin-inhibitor treatment.

Stage III Invasive Lobular Carcinoma: Angie's Patient Story

Patient Info: Angie, Female | Stage III

Angie completed 4 AC, 12 Taxol, and 30 rounds of radiation for Stage III grade 3 ILC, then continued Arimidex for a planned 10 years as of September 2021.

Lobular Breast Cancer AllianceRead more →

Invasive Lobular Carcinoma: Maureen's Patient Story

Patient Info: Maureen, Female

Biomarkers: Breast Cancer Index test used to guide duration of anti-estrogen therapy

Maureen completed double mastectomy and 30 radiation treatments for pleomorphic ILC and planned 10 years of anti-estrogen therapy based on Breast Cancer Index testing.

Lobular Breast Cancer AllianceRead more →

Triple-negative breast cancer first discovered through a duodenal metastasis

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative; CK7-positive; GATA3-positive; vimentin-positive; CDX2-negative; CK20-negative., triple negative

Metastatic Site: duodenum

She died two days after choosing comfort-focused care, following rapid decline from metastatic triple-negative breast cancer with duodenal involvement and small-bowel obstruction.

PubMed CentralRead more →

Stage IV gastric cancer with low platelets managed so chemotherapy could continue

Patient Info: Anonymized, female, 60s | Stage IV

Chemotherapy was able to continue after partial splenic embolization, but the gastric cancer later progressed and she died from the disease.

PubMed CentralRead more →

Stage IV gastric cancer with low platelets managed so chemotherapy could continue — Case 2

Patient Info: Anonymized, female, 70+ | Stage IV

After partial splenic embolization, her platelet count recovered and thrombocytopenia did not recur. She was receiving second-line ramucirumab plus paclitaxel at the latest follow-up.

PubMed CentralRead more →

ECMO-Supported Airway Tumor Removal in Stage IIB Lung Cancer

Patient Info: Anonymized, Male, 50s | Stage II

He recovered from the emergency airway procedure and remained on systemic cancer treatment at the last follow-up.

PubMed CentralRead more →

ECMO-Supported Airway Tumor Removal for Squamous Lung Cancer

Patient Info: Anonymized, Male, 60s

Bronchoscopy at three months found no malignancy, and he remained disease-free one year after hospital discharge.

PubMed CentralRead more →

Stage III HR-Positive Invasive Lobular Carcinoma: Jeanine's Patient Story

Patient Info: Jeanine, Female | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative; genetic testing negative

Jeanine completed chemotherapy, bilateral mastectomy, and post-surgery radiation after her disease was restaged from Stage II to Stage III, and she described continued active oncology care and advocacy as of June 2021.

Lobular Breast Cancer AllianceRead more →

MSI-High Malignant Struma Ovarii With Lung and Liver Metastases 17 Years Later

Patient Info: Anonymized, Female, 50s | Stage Metastatic/Advanced

Biomarkers: NRAS, and ATM mutations; Ki-67 approximately 15%–29%

Metastatic Site: lungs|liver

She remained asymptomatic and tolerated pembrolizumab without obvious adverse effects after 4 doses, with follow-up imaging planned for metastatic lung and liver disease.

PubMed CentralRead more →

Stage I EGFR Lung Adenocarcinoma: Ashley's Patient Story

Patient Info: Ashley Stringer, Female, Under 40 | Stage I

Biomarkers: EGFR-positive

As of May 2021, Ashley was 4 years from diagnosis after lobectomy and 2 radiation courses, with ongoing monitoring of lung nodules and possible future EGFR-targeted therapy if needed.

MD AndersonRead more →

Invasive Lobular Carcinoma: Susie's's Patient Story

Patient Info: Susie's daughter, Female, 40s

As of May 2021, Susie’s daughter was living after treatment for an 8 cm invasive lobular carcinoma and dealing with side effects from different endocrine therapies, while Susie became active in ILC advocacy and research support.

Lobular Breast Cancer AllianceRead more →

Male breast cancer discovered after years of stiff-person syndrome

Patient Info: Anonymized, Male, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative; anti-amphiphysin antibody positive at 1:64; hereditary cancer panel negative for pathogenic germline variants.

He completed curative-intent breast cancer treatment and reported substantial improvement in upper-body stiffness, although lower-extremity stiffness, cramps, and unsteadiness persisted.

PubMed CentralRead more →

Breast cancer returned in the stomach and peritoneum after three years in remission

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: Initial breast tumor: ER 95%, PR 5%, HER2-negative, Nottingham grade 2. Metastatic peritoneal tumor: ER 80%

Metastatic Site: stomach; peritoneum

After metastatic breast cancer was confirmed in the stomach and peritoneum, she chose palliative care and inpatient hospice and died a few weeks later.

PubMed CentralRead more →

Immunotherapy and surgery for lung adenocarcinoma with two brain metastases

Patient Info: Anonymized, Female, 50s

Biomarkers: PD-L1 100%; no actionable mutations on next-generation sequencing.

After brain surgery, radiation, 11 cycles of pembrolizumab, and lung surgery, she was off treatment and under observation in remission.

PubMed CentralRead more →